{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T22:52:29Z","timestamp":1766011949268,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>The authors report the case of a 20-year-old man who presented with a de novo episode of hypomania subsequent to the initiation of quinacrine for treatment resistant giardiasis. The hypomanic episode commenced some 20 days after the successful completion of a week long course of quinacrine 100 mg three times daily. The hypomanic episode was treated with olanzapine 10 mg daily. Two months subsequent to this, the patient developed a moderate depressive episode which was treated with escitalopram and olanzapine. One month after the resolution of the depressive episode, he once again presented with a hypomanic episode. The recurring episodes of discrete mood disturbance all occurred within 5 months of the commencement of quinacrine in an individual with no personal history of affective disorders.<\/jats:p>","DOI":"10.1136\/bcr.02.2012.5842","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T13:32:10Z","timestamp":1340371930000},"page":"bcr0220125842","source":"Crossref","is-referenced-by-count":3,"title":["Quinacrine induced mood disturbance \u2013 the unmasking of bipolar affective disorder"],"prefix":"10.1136","volume":"2012","author":[{"given":"John","family":"Lally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fintan","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.1","DOI":"10.1192\/bjp.133.5.429"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.2","DOI":"10.1038\/clpt.1981.154"},{"doi-asserted-by":"crossref","unstructured":"Beck AT Steer RA Brown GK . Manual for the Beck Depression Inventory\u2013II. San Antonio, Texas: Psychological Corporation 1996.","key":"2025082801051754000_2012.jun21_1.bcr0220125842.3","DOI":"10.1037\/t00742-000"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0891-5520(20)30540-7","article-title":"Giardiasis. Issues in diagnosis and management.","volume":"7","author":"Hill","year":"1993","journal-title":"Infect Dis Clin North Am"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.5","DOI":"10.1128\/CMR.14.1.114-128.2001"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.6","DOI":"10.1016\/S1474-4422(09)70049-3"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.2042-7158.1989.tb06421.x","article-title":"Pharmacokinetics of quinacrine after intrapleural instillation in rabbits and man.","volume":"41","author":"Bj\u00f6rkman","year":"1989","journal-title":"J Pharm Pharmacol"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.8","DOI":"10.1186\/1471-2334-4-53"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.9","first-page":"162","article-title":"Toxic psychosis following use of quinacrine.","volume":"42","author":"Lindenmayer","year":"1981","journal-title":"J Clin Psychiatry"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.10","DOI":"10.1001\/archderm.1984.01650420075020"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.11","first-page":"63","article-title":"Toxic psychosis following Atabrine","volume":"3","author":"Gaskill","year":"1945","journal-title":"Bull US Army Med Dept"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.12","DOI":"10.1097\/00007611-198203000-00029"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.13","DOI":"10.1002\/hup.427"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.14","DOI":"10.1016\/j.tmaid.2008.12.004"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.15","DOI":"10.1136\/bmj.313.7056.525"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v66n0207","article-title":"Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.","volume":"66","author":"van Riemsdijk","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JRS-2007-414","article-title":"Developing safe antimalaria drugs: key lessons from mefloquine and halofantrine","volume":"19","author":"Croft","year":"2007","journal-title":"Int J Risk & Safety Med"},{"doi-asserted-by":"publisher","key":"2025082801051754000_2012.jun21_1.bcr0220125842.18","DOI":"10.1097\/SMJ.0b013e318167a9e2"},{"key":"2025082801051754000_2012.jun21_1.bcr0220125842.19","first-page":"179","article-title":"Acute psychosis after mefloquine. Report of six cases.","volume":"47","author":"Sowunmi","year":"1995","journal-title":"Trop Geogr Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr.02.2012.5842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:05:23Z","timestamp":1756368323000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr.02.2012.5842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"references-count":19,"alternative-id":["10.1136\/bcr.02.2012.5842"],"URL":"https:\/\/doi.org\/10.1136\/bcr.02.2012.5842","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2012,6,22]]}}}